Immix Biopharma | Investor Presentation Deck

Slide schematic 7/7

list 2/2 metric 2/2 source-note 1/1 table 1/1 title 1/1

Components 7

bullet bullet big-number big-number source-note data headline

Tools 1

table/data: Market benchmarks for Multiple Myeloma therapies including Revlimid, Darzalex, Pomalyst, Abecma, and Carvykti with associated sales and status.

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

comparison-frame 90%

Side-by-side clinical data presentation for two distinct patient populations.

Find anything

The slide uses a two-column layout to contrast clinical results for Multiple Myeloma vs. AL Amyloidosis, supported by market data for existing therapies.